Universal cancer tasks, evolutionary tradeoffs, and the functions of driver mutations
暂无分享,去创建一个
Uri Alon | Carlos Caldas | Pablo Szekely | Jean Hausser | Hila Sheftel | Noam Bar | A Zimmer | U. Alon | Jean Hausser | C. Caldas | J. Hausser | N. Bar | A. Zimmer | Pablo Szekely | H. Sheftel
[1] Ville Mustonen,et al. Correction to: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature, (2016), 534, 7605, (47-54), 10.1038/nature17676) , 2019 .
[2] The Cancer Genome Atlas Research Network,et al. Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.
[3] N. Rosenfeld,et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes , 2016, Nature Communications.
[4] A. Services,et al. Integrated genomic and molecular characterization of cervical cancer. , 2017 .
[5] Gerhard Christofori,et al. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? , 2016, Current opinion in cell biology.
[6] Adam A. Margolin,et al. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity , 2012, Nature.
[7] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[8] Robert A. Gatenby,et al. Life history trade-offs in cancer evolution , 2013, Nature Reviews Cancer.
[9] P. Sorger,et al. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.
[10] C. Tognon,et al. Reduced proliferation and enhanced migration: Two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1 , 2009, Cell cycle.
[11] Susan M. Butler,et al. Going against the grain: chemotaxis and infection in Vibrio cholerae , 2005, Nature Reviews Microbiology.
[12] Richard A. Moore,et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy , 2017, Nature.
[13] M. Blasco. Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.
[14] Johan Hartman,et al. Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing , 2018, Cell.
[15] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[16] Michael P. Schroeder,et al. IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.
[17] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[18] Allan Jacobson,et al. NMD: a multifaceted response to premature translational termination , 2012, Nature Reviews Molecular Cell Biology.
[19] Benjamin D. Simons,et al. Defining the mode of tumour growth by clonal analysis , 2012, Nature.
[20] Sebastian Munck,et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. , 2010, Cancer research.
[21] R. Deshaies,et al. Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy , 2014, BMC Biology.
[22] O Shoval,et al. Evolutionary Trade-Offs, Pareto Optimality, and the Geometry of Phenotype Space , 2012, Science.
[23] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[24] Dolph Schluter,et al. ADAPTIVE RADIATION ALONG GENETIC LINES OF LEAST RESISTANCE , 1996, Evolution; international journal of organic evolution.
[25] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[26] Krishnendu Chatterjee,et al. Reconstructing metastatic seeding patterns of human cancers , 2017, Nature Communications.
[27] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[28] Mark M. Davis,et al. Cell type–specific gene expression differences in complex tissues , 2010, Nature Methods.
[29] S. Beloribi-Djefaflia,et al. Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.
[30] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[31] M. Simon,et al. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. , 2014, Trends in cell biology.
[32] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[33] Y. Benjamini,et al. Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.
[34] C. Semenkovich,et al. Peroxisomes: a nexus for lipid metabolism and cellular signaling. , 2014, Cell metabolism.
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[37] Krister Wennerberg,et al. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia. , 2013, Cancer discovery.
[38] Robert J Gillies,et al. Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow , 2018, Nature Reviews Cancer.
[39] Uri Alon,et al. Inferring biological tasks using Pareto analysis of high-dimensional data , 2015, Nature Methods.
[40] S. Ferdinandusse,et al. Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum , 2016, Front. Cell Dev. Biol..
[41] M. Erlacher,et al. How cell death shapes cancer , 2015, Cell Death and Disease.
[42] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[43] The Cancer Genome Atlas Research Network. COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.
[44] Steven J. M. Jones,et al. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma , 2017, Cell.
[45] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[46] Steven J. M. Jones,et al. Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.
[47] David C. Jones,et al. Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.
[48] Charles H. Yoon,et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.
[49] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[50] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[51] Uri Alon,et al. Evolutionary trade-offs and the structure of polymorphisms , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.
[52] Michelle Monje,et al. Neuronal Activity in Ontogeny and Oncology. , 2017, Trends in cancer.
[53] Steven J. M. Jones,et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.
[54] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[55] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[56] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[57] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[58] M. Stratton,et al. A census of amplified and overexpressed human cancer genes , 2010, Nature Reviews Cancer.
[59] Yuval Hart,et al. Geometry of the Gene Expression Space of Individual Cells , 2015, PLoS Comput. Biol..
[60] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[61] R. Gillies,et al. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work , 2012, Nature Reviews Cancer.
[62] Ali Bashashati,et al. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes , 2017, Nature Genetics.
[63] T. Hwa,et al. Interdependence of Cell Growth and Gene Expression: Origins and Consequences , 2010, Science.
[64] Andreas Wagner,et al. Energy constraints on the evolution of gene expression. , 2005, Molecular biology and evolution.
[65] S. Leibler,et al. Bacterial Persistence as a Phenotypic Switch , 2004, Science.
[66] Jing Yang,et al. Epithelial–mesenchymal plasticity in carcinoma metastasis , 2013, Genes & development.
[67] Y. Liu,et al. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer , 2006, Prostate Cancer and Prostatic Diseases.
[68] Martin L. Miller,et al. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.
[69] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[70] K. Schaller,et al. 'Go or grow': the key to the emergence of invasion in tumour progression? , 2012, Mathematical medicine and biology : a journal of the IMA.
[71] Steven J. M. Jones,et al. Integrated genomic and molecular characterization of cervical cancer , 2017, Nature.
[72] Charles H. Graham,et al. Hypoxia-driven selection of the metastatic phenotype , 2007, Cancer and Metastasis Reviews.
[73] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[74] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[75] Adam B. Olshen,et al. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis , 2009, Bioinform..
[76] Carlos Caldas,et al. A new genome‐driven integrated classification of breast cancer and its implications , 2013, The EMBO journal.
[77] M. Lynch,et al. The bioenergetic costs of a gene , 2015, Proceedings of the National Academy of Sciences.
[78] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[79] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[80] Joshua M. Stuart,et al. Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.
[81] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[82] D. Berger,et al. Perineural invasion in cancer , 2009, Cancer.
[83] G. Getz,et al. Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.
[84] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[85] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[86] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.